ATE86965T1 - Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. - Google Patents

Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.

Info

Publication number: ATE86965T1
Authority: AT; Austria
Prior art keywords: pct; treatment; adrenoleucodystrophy; pharmaceutical compositions; date sep
Prior art date: 1988-02-23

Application number

AT88904245T

Other languages

English (en)

Inventor

Donald Suddaby

Keith Coupland

Original Assignee

Croda Int Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-23

Filing date

1988-05-13

Publication date

1993-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE86965(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-05-13 Application filed by Croda Int Plc filed Critical Croda Int Plc

1993-04-15 Application granted granted Critical

1993-04-15 Publication of ATE86965T1 publication Critical patent/ATE86965T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
201000011452 Adrenoleukodystrophy Diseases 0.000 abstract 1
DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 abstract 1
URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 abstract 1
102000009030 Member 1 Subfamily D ATP Binding Cassette Transporter Human genes 0.000 abstract 1
108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 abstract 1
150000003626 triacylglycerols Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
- C07C67/54—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Crystallography & Structural Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)
Edible Oils And Fats (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)

AT88904245T 1988-02-23 1988-05-13 Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. ATE86965T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB888804188A GB8804188D0 (en)	1988-02-23	1988-02-23	Pharmaceutical compositions
EP88904245A EP0360821B1 (de)	1988-02-23	1988-05-13	Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie
PCT/GB1988/000373 WO1989008095A1 (en)	1988-02-23	1988-05-13	Pharmaceutical compositions for treating adrenoleukodystrophy

Publications (1)

Publication Number	Publication Date
ATE86965T1 true ATE86965T1 (de)	1993-04-15

Family

ID=10632210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88904245T ATE86965T1 (de)	1988-02-23	1988-05-13	Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.

Country Status (10)

Country	Link
US (1)	US5331009A (de)
EP (1)	EP0360821B1 (de)
JP (1)	JPH0667869B2 (de)
AT (1)	ATE86965T1 (de)
CA (1)	CA1308028C (de)
DE (1)	DE3879489T2 (de)
DK (1)	DK521389A (de)
GB (1)	GB8804188D0 (de)
NO (1)	NO894083D0 (de)
WO (1)	WO1989008095A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9416846D0 (en) *	1994-08-19	1994-10-12	Croda Int Plc	Lipid supplementation
CA2344717A1 (en)	1998-09-28	2000-04-06	The Johns Hopkins University	Adrenoleukodystrophy treatments and drug screening
JP2001278786A (ja) *	2000-03-29	2001-10-10	Morinaga Milk Ind Co Ltd	高尿酸性疾患予防治療剤
EP3165591B1 (de)	2014-07-02	2024-05-22	Nissui Corporation	Verfahren zur herstellung von aus einem meeresprodukt abgeleiteten monovalenten ungesättigten freien fettsäuren oder niedrigen alkoholestern davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4442125A (en) *	1978-06-26	1984-04-10	Oxford Hill, Ltd.	Process for detaching or preventing attachment of microorganisms to a surface
US4377526A (en) *	1981-05-15	1983-03-22	Nippon Suisan Kaisha, Ltd.	Method of purifying eicosapentaenoic acid and its esters
US4843095A (en) *	1987-08-07	1989-06-27	Century Laboratories, Inc.	Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis

1988
- 1988-02-23 GB GB888804188A patent/GB8804188D0/en active Pending
- 1988-05-13 EP EP88904245A patent/EP0360821B1/de not_active Expired - Lifetime
- 1988-05-13 US US07/411,484 patent/US5331009A/en not_active Expired - Lifetime
- 1988-05-13 AT AT88904245T patent/ATE86965T1/de not_active IP Right Cessation
- 1988-05-13 JP JP63504109A patent/JPH0667869B2/ja not_active Expired - Lifetime
- 1988-05-13 DE DE8888904245T patent/DE3879489T2/de not_active Expired - Fee Related
- 1988-05-13 WO PCT/GB1988/000373 patent/WO1989008095A1/en not_active Ceased
- 1988-06-30 CA CA000570988A patent/CA1308028C/en not_active Expired - Fee Related
1989
- 1989-10-12 NO NO894083A patent/NO894083D0/no unknown
- 1989-10-20 DK DK521389A patent/DK521389A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB8804188D0 (en)	1988-03-23
JPH0667869B2 (ja)	1994-08-31
NO894083L (no)	1989-10-12
DE3879489D1 (de)	1993-04-22
WO1989008095A1 (en)	1989-09-08
US5331009A (en)	1994-07-19
EP0360821B1 (de)	1993-03-17
DK521389A (da)	1989-12-15
NO894083D0 (no)	1989-10-12
JPH02503792A (ja)	1990-11-08
EP0360821A1 (de)	1990-04-04
CA1308028C (en)	1992-09-29
DK521389D0 (da)	1989-10-20
DE3879489T2 (de)	1993-06-24

Similar Documents

Publication	Publication Date	Title
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
MA23170A1 (fr)	1994-12-31	Procede de preparation d'un nouveau compose .
CA2285203A1 (en)	1998-09-17	Compositions containing capsaicin or capsaicin analogues and a local anesthetic
GR3019315T3 (en)	1996-06-30	Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
EP0221041A3 (de)	1987-10-28	Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
DE58901401D1 (de)	1992-06-17	Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
ATE220321T1 (de)	2002-07-15	Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
IT1170214B (it)	1987-06-03	Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE99172T1 (de)	1994-01-15	Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
NZ225950A (en)	1991-10-25	Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions
DE3483338D1 (de)	1990-11-08	Pharmazeutische peptide, ihre herstellung und verwendung sowie zwischenprodukte.
ATE88633T1 (de)	1993-05-15	Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
HUT57204A (en)	1991-11-28	Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ATE86965T1 (de)	1993-04-15	Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
GR890100563A (el)	1990-10-31	Προαγωγη της αναπτυξεως χοιρων.
DE3878154D1 (de)	1993-03-18	Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ATE45090T1 (de)	1989-08-15	Pharmazeutische zusammensetzung in oralen darreichungsformen.
RU96111879A (ru)	1998-12-10	Способ приготовления гомеопатических мягких лекарственных форм
ATE73326T1 (de)	1992-03-15	Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
KR940008688A (ko)	1994-05-16	필수지방산에 의해 킬레이트화된 아연정제
CA2161683A1 (en)	1994-11-10	Veterinary composition containing a proton pump inhibitor
UA15281A (uk)	1997-06-30	Спосіб лікуваhhя хроhічhої ішемічhої хвороби серця
ATE32514T1 (de)	1988-03-15	3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR880012206A (ko)	1988-11-26	구강질환 치료 조성물

Legal Events

Date	Code	Title	Description
1993-09-15	UEP	Publication of translation of european patent specification
1999-02-15	REN	Ceased due to non-payment of the annual fee